Pregnancy Outcomes in Non-Criteria Obstetric Antiphospholipid Syndrome: Analysis of a Cohort of 91 Patients

被引:0
作者
Beca, Sara [1 ,2 ]
Banos, Nuria [2 ,3 ,4 ]
Borrell, Maria [3 ,4 ]
Ruiz-Ortiz, Estibaliz [2 ,5 ]
Perez-Isidro, Albert [2 ,5 ]
Cervera, Ricard [1 ,2 ]
Reverter, Joan Carles [2 ,6 ]
Tassies, Dolores [2 ,6 ]
Espinosa, Gerard [1 ,2 ]
机构
[1] Univ Barcelona, Hosp Clin, ERNReCONNET, Catalan & Spanish Hlth Syst,Dept Autoimmune Dis,Re, Barcelona 08036, Catalonia, Spain
[2] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona 08036, Catalonia, Spain
[3] Univ Barcelona, Hosp St Joan Deu, Barcelona Ctr Maternal Fetal & Neonatal Med, BCNatal,Dept Maternal Fetal Med, Barcelona 08028, Catalonia, Spain
[4] Univ Barcelona, Hosp Clin, Barcelona 08028, Catalonia, Spain
[5] Univ Barcelona, Hosp Clin, Ctr Diagnost Biomed CDB, Dept Immunol, Barcelona 08036, Catalonia, Spain
[6] Univ Barcelona, Hosp Clin, Dept Hemotherapy & Hemostasis, Barcelona 08036, Catalonia, Spain
关键词
non-criteria obstetric antiphospholipid syndrome; adverse pregnancy outcomes; aspirin; heparin; INTERNATIONAL CONSENSUS STATEMENT; SYNDROME SCORE; CLASSIFICATION CRITERIA; RISK STRATIFICATION; ANTIBODIES; ASPIRIN; UPDATE;
D O I
10.3390/jcm13247862
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The clinical and laboratory features of patients with non-criteria obstetric antiphospholipid syndrome (NC-OAPS), as well as their pregnancy outcomes and ideal treatment are not clearly determined. The aim of this study is to describe the characteristics and outcomes of pregnancies in NC-OAPS and compare them with an obstetric APS (OAPS) cohort. Methods: This is a retrospective study conducted on a cohort of women referred to a high-risk obstetric unit of a tertiary hospital. Women that were classified as having OAPS or NC-OAPS were included and compared in terms of clinical and laboratory characteristics, management, and subsequent pregnancy outcomes. Results: We identified 107 women with 143 pregnancies, 91 with NC-OAPS and 16 with OAPS. There were no differences in demographic features between both groups. Women with NC-OAPS were more likely to have recurrent implantation failure and were predominantly positive for a single antiphospholipid antibody (aPL) subtype. Both groups were treated similarly (low dose aspirin plus low molecular weight heparin in 87.4% of NC-OAPS and 83.3% of OAPS, p > 0.05). Live birth rate (82.4% and 75.0%, respectively, p > 0.05) and adverse pregnancy outcomes (31.6% vs. 37.5%, p > 0.05) in subsequent pregnancies during follow-up were also similar between groups. Conclusions: This study revealed differences in the previous pregnancy morbidity and aPL profiles in women with NC-OAPS and OAPS, although the therapeutic approach and the outcomes of subsequent pregnancies were similar in both groups.
引用
收藏
页数:13
相关论文
共 50 条
[41]   Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study [J].
Saccone, Gabriele ;
Berghella, Vincenzo ;
Maruotti, Giuseppe Maria ;
Ghi, Tullio ;
Rizzo, Giuseppe ;
Simonazzi, Giuliana ;
Rizzo, Nicola ;
Facchinetti, Fabio ;
Dall'Asta, Andrea ;
Visentin, Silvia ;
Sarno, Laura ;
Xodo, Serena ;
Bernabini, Dalila ;
Monari, Francesca ;
Roman, Amanda ;
Eke, Ahizechukwu Chigoziem ;
Hoxha, Ariela ;
Ruffatti, Amelia ;
Schuit, Ewoud ;
Martinelli, Pasquale .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2017, 216 (05)
[42]   The obstetric outcome following treatment in a cohort of patients with antiphospholipid antibody syndrome in a tertiary care center [J].
Dadhwal, V ;
Sharma, A. K. ;
Deka, D. ;
Gupta, B. ;
Mittal, S. .
JOURNAL OF POSTGRADUATE MEDICINE, 2011, 57 (01) :16-19
[43]   Obstetric outcomes in patients with primary thrombotic and obstetric antiphospholipid syndrome and its relation to the antiphospholipid antibody profile [J].
Hogden, A. ;
Antovic, A. ;
Berg, E. ;
Bremme, K. ;
Chaireti, R. .
LUPUS, 2019, 28 (07) :868-877
[44]   Pregnancy failure in patients with obstetric antiphospholipid syndrome with conventional treatment: the influence of a triple positive antibody profile [J].
Latino, J. O. ;
Udry, S. ;
Aranda, F. M. ;
Peres Wingeyer, S. D. A. ;
Fernandez Romero, D. S. ;
de Larranaga, G. F. .
LUPUS, 2017, 26 (09) :983-988
[45]   Thrombocytopenia in the first trimester predicts adverse pregnancy outcomes in obstetric antiphospholipid syndrome [J].
Jin, Jiayang ;
Xu, Xue ;
Hou, Lei ;
Hou, Yuke ;
Li, Jing ;
Liang, Meiying ;
Li, Chun .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[46]   Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements [J].
Zigon, Polona ;
Podovsovnik, Anuska ;
Ambrozic, Ales ;
Tomsic, Matija ;
Hocevar, Alojzija ;
Gaspersic, Natasa ;
Rotar, Ziga ;
Praprotnik, Sonja ;
Semrl, Snezna Sodin ;
Cucnik, Sasa .
CLINICAL RHEUMATOLOGY, 2019, 38 (02) :371-378
[47]   A Pilot Open-Label Phase II Trial of Rituximab for Non-Criteria Manifestations of Antiphospholipid Syndrome [J].
Erkan, Doruk ;
Vega, JoAnn ;
Ramon, Glendalee ;
Kozora, Elizabeth ;
Lockshin, Michael D. .
ARTHRITIS AND RHEUMATISM, 2013, 65 (02) :464-471
[48]   Clinical features and pregnancy outcome in antiphospholipid syndrome patients with history of severe pregnancy complications [J].
Matsuki, Yuko ;
Atsumi, Tatsuya ;
Yamaguchi, Koushi ;
Hisano, Michi ;
Arata, Naoko ;
Oku, Kenji ;
Watanabe, Noriyoshi ;
Sago, Haruhiko ;
Takasaki, Yoshinari ;
Murashima, Atsuko .
MODERN RHEUMATOLOGY, 2015, 25 (02) :215-218
[49]   Obstetric antiphospholipid syndrome: early variations of angiogenic factors are associated with adverse outcomes [J].
Cochery-Nouvellon, Eva ;
Mercier, Erick ;
Bouvier, Sylvie ;
Balducchi, Jean-Pierre ;
Quere, Isabelle ;
Perez-Martin, Antonia ;
Mousty, Eve ;
Letouzey, Vincent ;
Gris, Jean-Christophe .
HAEMATOLOGICA, 2017, 102 (05) :835-842
[50]   Non-criteria antiphospholipid antibodies and pediatric rheumatic disease: a case series [J].
Mahmud, Shawn A. ;
Bullock, Danielle R. ;
Correll, Colleen K. ;
Hobday, Patricia M. ;
Riskalla, Mona M. ;
Vehe, Richard K. ;
Binstadt, Bryce A. .
PEDIATRIC RHEUMATOLOGY, 2022, 20 (01)